
Sun Jae Yoo
Examiner (ID: 4021, Phone: (571)272-9074 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1622, 1609, 1626, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1172 |
| Pending Applications | 219 |
| Abandoned Applications | 564 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19274398
[patent_doc_number] => 12024509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Therapeutic compounds as inhibitors of the orexin-1 receptor
[patent_app_type] => utility
[patent_app_number] => 16/814328
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52001
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 865
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/814328 | Therapeutic compounds as inhibitors of the orexin-1 receptor | Mar 9, 2020 | Issued |
Array
(
[id] => 16120169
[patent_doc_number] => 20200212107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => PHOTOELECTRIC CONVERSION ELEMENT, OPTICAL SENSOR, AND IMAGING ELEMENT
[patent_app_type] => utility
[patent_app_number] => 16/812378
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16812378
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/812378 | Photoelectric conversion element, optical sensor, and imaging element | Mar 8, 2020 | Issued |
Array
(
[id] => 17609672
[patent_doc_number] => 20220151951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => Preparation for topical use for dermatological treatments
[patent_app_type] => utility
[patent_app_number] => 17/436636
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436636
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436636 | Preparation for topical use for dermatological treatments | Mar 8, 2020 | Abandoned |
Array
(
[id] => 16312315
[patent_doc_number] => 20200291053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => METAL COMPLEX AS SENSOR COMPOUND FOR DETECTING GAS ANALYTE
[patent_app_type] => utility
[patent_app_number] => 16/811678
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1441
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811678
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/811678 | Metal complex as sensor compound for detecting gas analyte | Mar 5, 2020 | Issued |
Array
(
[id] => 17672648
[patent_doc_number] => 20220185815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => PYRROLOPYRAZOLE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/436500
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436500 | Pyrrolopyrazole derivative | Mar 4, 2020 | Issued |
Array
(
[id] => 17625678
[patent_doc_number] => 20220160693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => PHARMACEUTICAL COMPOSITION OF PROLYL HYDROXYLASE INHIBITOR AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/434831
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/434831 | PHARMACEUTICAL COMPOSITION OF PROLYL HYDROXYLASE INHIBITOR AND PREPARATION METHOD THEREFOR | Mar 2, 2020 | Abandoned |
Array
(
[id] => 19674563
[patent_doc_number] => 12186401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Amide-based proteolysis modulators of B-rapidly accelerated fibrosarcoma (BRAF) and associated uses
[patent_app_type] => utility
[patent_app_number] => 17/310837
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15562
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310837
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310837 | Amide-based proteolysis modulators of B-rapidly accelerated fibrosarcoma (BRAF) and associated uses | Mar 1, 2020 | Issued |
Array
(
[id] => 17576802
[patent_doc_number] => 20220133657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => COMPOUNDS FOR PREVENTION AND TREATMENT OF OBESITY AND RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/435678
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435678
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435678 | Compounds for prevention and treatment of obesity and related disorders | Mar 1, 2020 | Issued |
Array
(
[id] => 18280556
[patent_doc_number] => 20230096028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => BICYCLIC HETEROCYCLYL COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/310932
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 404
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310932 | BICYCLIC HETEROCYCLYL COMPOUNDS AND USES THEREOF | Mar 1, 2020 | Abandoned |
Array
(
[id] => 17627160
[patent_doc_number] => 20220162175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => METHOD FOR PRODUCING N-(HYDROCARBON)ISOCYANURIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/434803
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434803
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/434803 | Method for producing N-(hydrocarbon)isocyanuric acid | Mar 1, 2020 | Issued |
Array
(
[id] => 17759866
[patent_doc_number] => 20220233478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING HYDROXYUREA FOR USE IN THE TREATMENT OF SEVERE CHRONIC ANEMIA
[patent_app_type] => utility
[patent_app_number] => 17/433869
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4129
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433869 | PHARMACEUTICAL COMPOSITION CONTAINING HYDROXYUREA FOR USE IN THE TREATMENT OF SEVERE CHRONIC ANEMIA | Feb 27, 2020 | Abandoned |
Array
(
[id] => 17561652
[patent_doc_number] => 20220125801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => OPHTHALMIC COMPOSITION OF BIMATOPROST
[patent_app_type] => utility
[patent_app_number] => 17/435095
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435095 | OPHTHALMIC COMPOSITION OF BIMATOPROST | Feb 26, 2020 | Abandoned |
Array
(
[id] => 20633403
[patent_doc_number] => 12594266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-07
[patent_title] => Triterpenoid antifungals for the treatment or prevention of
[patent_app_type] => utility
[patent_app_number] => 17/432926
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6648
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432926
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432926 | Triterpenoid antifungals for the treatment or prevention of | Feb 24, 2020 | Issued |
Array
(
[id] => 17362615
[patent_doc_number] => 11229623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-25
[patent_title] => TRPV4 antagonists
[patent_app_type] => utility
[patent_app_number] => 16/796989
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48279
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 404
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/796989 | TRPV4 antagonists | Feb 20, 2020 | Issued |
Array
(
[id] => 17680967
[patent_doc_number] => 11365206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => BCL-2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/795720
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25517
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 689
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795720
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795720 | BCL-2 inhibitors | Feb 19, 2020 | Issued |
Array
(
[id] => 17546642
[patent_doc_number] => 20220117983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => METHODS FOR TREATING LIVER CANCERS USING AN ORALLY ADMINISTERED DIOXOLANE NUCLEOTIDE IN COMBINATION WITH AN ANTI-PD1 OR ANTI-PDL1 MONOCLONAL ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 17/431686
[patent_app_country] => US
[patent_app_date] => 2020-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431686
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431686 | Methods for treating liver cancers using an orally administered dioxolane nucleotide in combination with an anti-PD1 or anti-PDL1 monoclonal antibody | Feb 16, 2020 | Issued |
Array
(
[id] => 17473938
[patent_doc_number] => 20220081442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => 3,6-DISUBSTITUTED-2-PYRIDINALDOXIME SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 17/430876
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430876 | 3,6-disubstituted-2-pyridinaldoxime scaffolds | Feb 13, 2020 | Issued |
Array
(
[id] => 20115996
[patent_doc_number] => 12365685
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Substituted fused aromatic ring derivative, composition and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/426373
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15913
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426373
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426373 | Substituted fused aromatic ring derivative, composition and use thereof | Feb 12, 2020 | Issued |
Array
(
[id] => 19701788
[patent_doc_number] => 12195804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Treatment of squamous cell carcinoma
[patent_app_type] => utility
[patent_app_number] => 16/790471
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 69
[patent_no_of_words] => 24628
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790471
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790471 | Treatment of squamous cell carcinoma | Feb 12, 2020 | Issued |
Array
(
[id] => 17655256
[patent_doc_number] => 20220175721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => TREATMENT FOR POLYCYSTIC OVARIAN SYNDROME (PCOS)
[patent_app_type] => utility
[patent_app_number] => 17/430381
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430381 | TREATMENT FOR POLYCYSTIC OVARIAN SYNDROME (PCOS) | Feb 11, 2020 | Abandoned |